$12.69
+0.76 (+6.37%)
Open$11.89
Previous Close$11.93
Day High$12.93
Day Low$11.81
52W High$18.69
52W Low$6.92
Volume—
Avg Volume878.4K
Market Cap894.53M
P/E Ratio—
EPS$-1.24
SectorBiotechnology
Analyst Ratings
Strong Buy
20 analysts
Price Target
+95.2% upside
Current
$12.69
$12.69
Target
$24.77
$24.77
$14.60
$24.77 avg
$27.54
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 119.24M | 130.50M | 205.11M |
| Net Income | -87,281,762 | -85,973,060 | -12,900,416 |
| Profit Margin | -73.2% | -69.5% | -6.3% |
| EBITDA | -167,331,163 | -173,978,991 | -15,864,221 |
| Free Cash Flow | — | — | -6,278,593 |
| Rev Growth | -8.6% | -8.6% | +24.6% |
| Debt/Equity | 0.19 | 0.19 | 0.13 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |